Your browser doesn't support javascript.
loading
Type 1 interferons as a potential treatment against COVID-19.
Sallard, Erwan; Lescure, François-Xavier; Yazdanpanah, Yazdan; Mentre, France; Peiffer-Smadja, Nathan.
Afiliação
  • Sallard E; École Normale Supérieure de Paris, 45 Rue D'Ulm, 75005, Paris, France.
  • Lescure FX; Université de Paris, IAME, INSERM, F-75018, Paris, France; Department of Infectious and Tropical Diseases, Assistance Publique - Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France.
  • Yazdanpanah Y; Université de Paris, IAME, INSERM, F-75018, Paris, France; Department of Infectious and Tropical Diseases, Assistance Publique - Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France.
  • Mentre F; Université de Paris, IAME, INSERM, F-75018, Paris, France.
  • Peiffer-Smadja N; Université de Paris, IAME, INSERM, F-75018, Paris, France; Department of Infectious and Tropical Diseases, Assistance Publique - Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France. Electronic address: nathan.peiffer-smadja@inserm.fr.
Antiviral Res ; 178: 104791, 2020 06.
Article em En | MEDLINE | ID: mdl-32275914

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Interferon Tipo I / Infecções por Coronavirus Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Interferon Tipo I / Infecções por Coronavirus Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article